
Tigedeep 90mg Tablet
Marketer
Deepkamal Health Services Private Limited
Salt Composition
Ticagrelor (90mg)
Overview Tigedeep 90mg Tablet
Ticagrelor 90mg tablets are antiplatelet agents, preventing blood clot formation within blood vessels. This action safeguards against heart attacks and strokes in individuals with existing heart conditions. These tablets are also indicated for patients recovering from a recent heart attack, experiencing severe chest pain (unstable angina), or post-stenting. Their use minimizes the risk of recurrent heart attacks, strokes, or stent-related clots. Concurrent use with aspirin, another antiplatelet medication, is typically prescribed. Ticagrelor 90mg may be administered with or without food, consistently at the same time daily; continued use is crucial, even during periods of well-being. Discontinuing treatment elevates the risk of cardiovascular events. The most frequent adverse effect is increased bleeding tendency, potentially prolonging bleeding times from injuries. While usually mild and self-resolving, prolonged or worsening bleeding requires medical attention. Some patients report mild shortness of breath, generally subsiding with continued therapy; persistent or intensifying breathlessness should be reported. This medication is contraindicated for individuals with active internal bleeding (e.g., stomach ulcers, intracranial hemorrhage) or liver disease. Pre-existing conditions should be disclosed to your physician before initiating treatment.
Uses of Tigedeep 90mg Tablet
Reducing the risk of cardiac arrest and cerebrovascular events
Major Benefits of Tigedeep 90mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tigedeep 90mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Tigedeep 90mg Tablet:
- Bleeding
- Breathlessness
How to use Tigedeep 90mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tigedeep 90mg Tablets can be consumed with or without food, however, consistent timing is recommended.
How Tigedeep 90mg Tablet works:
Tigedeep 90mg tablets inhibit platelet aggregation, a process crucial in blood clot formation. This antiplatelet action reduces the risk of cardiovascular events such as stroke and heart attack.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Tigedeep 90mg Tablet concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Tigedeep 90mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any possible dangers prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Tigedeep 90mg Tablet with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Tigedeep 90mg Tablets.
KidneySAFE IF PRESCRIBED
Tigedeep 90mg tablets are considered safe for patients with impaired kidney function, and no dosage modification is necessary. Data regarding the use of Tigedeep 90mg tablets in individuals undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with hepatic impairment should use 90mg Tigedeep tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Tigedeep 90mg tablets are contraindicated in individuals with severe liver dysfunction.
What if you forget to take Tigedeep 90mg Tablet :
Should you forget a Tigedeep 90mg Tablet dose, take it immediately. If your next dose is nearly due, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Tigedeep 90mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Triazolo[1,5-a]pyrimidines |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |
